KR20030086314A - 암 치료를 위한 레티노이드 수용체 리간드 및 선별된세포독성제의 상승적 조합 - Google Patents

암 치료를 위한 레티노이드 수용체 리간드 및 선별된세포독성제의 상승적 조합 Download PDF

Info

Publication number
KR20030086314A
KR20030086314A KR10-2003-7012217A KR20037012217A KR20030086314A KR 20030086314 A KR20030086314 A KR 20030086314A KR 20037012217 A KR20037012217 A KR 20037012217A KR 20030086314 A KR20030086314 A KR 20030086314A
Authority
KR
South Korea
Prior art keywords
rarα
formula
selected cytotoxic
rar
paclitaxel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR10-2003-7012217A
Other languages
English (en)
Korean (ko)
Inventor
발레리 산드린 비바-한나
매튜 브이. 로렌지
마르코 엠. 고타르디스
프레드 크리스토퍼 주시
Original Assignee
브리스톨-마이어스스퀴브컴파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨-마이어스스퀴브컴파니 filed Critical 브리스톨-마이어스스퀴브컴파니
Publication of KR20030086314A publication Critical patent/KR20030086314A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR10-2003-7012217A 2001-03-22 2002-03-22 암 치료를 위한 레티노이드 수용체 리간드 및 선별된세포독성제의 상승적 조합 Withdrawn KR20030086314A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27775401P 2001-03-22 2001-03-22
US60/277,754 2001-03-22
PCT/US2002/008718 WO2002078620A2 (en) 2001-03-22 2002-03-22 Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer

Publications (1)

Publication Number Publication Date
KR20030086314A true KR20030086314A (ko) 2003-11-07

Family

ID=23062213

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7012217A Withdrawn KR20030086314A (ko) 2001-03-22 2002-03-22 암 치료를 위한 레티노이드 수용체 리간드 및 선별된세포독성제의 상승적 조합

Country Status (15)

Country Link
EP (1) EP1383491A2 (https=)
JP (1) JP2004528316A (https=)
KR (1) KR20030086314A (https=)
CN (1) CN1498105A (https=)
BR (1) BR0207681A (https=)
CA (1) CA2441335A1 (https=)
CZ (1) CZ20032540A3 (https=)
DE (1) DE02733871T1 (https=)
ES (1) ES2214985T1 (https=)
HU (1) HUP0400255A2 (https=)
IL (1) IL157358A0 (https=)
MX (1) MXPA03008403A (https=)
PL (1) PL368946A1 (https=)
TR (1) TR200400812T3 (https=)
WO (1) WO2002078620A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5113038B2 (ja) * 2006-03-23 2013-01-09 テムリック株式会社 癌治療用キットおよび癌治療用医薬組成物

Also Published As

Publication number Publication date
CN1498105A (zh) 2004-05-19
PL368946A1 (pl) 2005-04-04
IL157358A0 (en) 2004-02-19
BR0207681A (pt) 2004-07-27
HUP0400255A2 (hu) 2004-08-30
DE02733871T1 (de) 2004-08-26
TR200400812T3 (tr) 2004-07-21
ES2214985T1 (es) 2004-10-01
JP2004528316A (ja) 2004-09-16
WO2002078620A2 (en) 2002-10-10
CA2441335A1 (en) 2002-10-10
CZ20032540A3 (cs) 2004-05-12
WO2002078620A3 (en) 2003-04-17
MXPA03008403A (es) 2004-01-29
EP1383491A2 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
Ablain et al. Retinoic acid signaling in cancer: the parable of acute promyelocytic leukemia
US6130230A (en) Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
Zusi et al. Selective retinoids and rexinoids in cancer therapy and chemoprevention
US20120034210A1 (en) Compositions for potentiating apoposis signals in tumour cells
Lo et al. Effects of all-trans retinoic acid, retinol, and β-carotene on murine macrophage activity
Nagpal et al. Retinoids as anti-cancer agents
AU701790B2 (en) Method for treating cancers using 6-{3-{1-adamantyl}- 4-hydroxyphenyl}
Zhu Vitamin A and its derivatives-retinoic acid and retinoid pharmacology
US20080255244A1 (en) CaM Kinase II Inhibitor Improves Retinoic Acid Therapy and Inhibits the Proliferation of Myeloid Leukemia Cells
Traves et al. Selective activation of liver X receptors by acanthoic acid-related diterpenes
Garcia-Bates et al. Role of peroxisome proliferator‐activated receptor gamma and its ligands in the treatment of hematological malignancies
Lei et al. 1, 1-Bis (3′-indolyl)-1-(p-substituted phenyl) methanes inhibit ovarian cancer cell growth through peroxisome proliferator–activated receptor–dependent and independent pathways
WO1998048055A1 (en) Methods and compositions for use in modulating expression of matrix metalloproteinase genes
JP2002542268A (ja) 過増殖性疾患の処置組成物および方法
US20040122080A1 (en) Synergist combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
KR20030086314A (ko) 암 치료를 위한 레티노이드 수용체 리간드 및 선별된세포독성제의 상승적 조합
JP2013177329A (ja) Ｒｘｒパーシャルアゴニスト
TW200536549A (en) Enhancement of anti-androgenic activity by a combination of inhibitors targeting different steps of a steroid-dependent gene activation pathway and uses thereof
Marchwicka et al. Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review
US20020090352A1 (en) Compositions and methods for use in modulating immune system function
AU2002305072A1 (en) Synergistic combinations of retinoid receptor ligands and selected cytotoxic agents for treatment of cancer
WO2002022113A2 (en) Retinoic acid receptor antagonists as promoters of angiogenesis
CN104237536A (zh) 黄酮类化合物刺槐素及衍生物的用途
WO2011103563A1 (en) Methods and compositions for inhibiting and preventing the growth of malignant mast cells
JP4904498B2 (ja) Ｒａｒ活性化を起こす天然化合物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20030919

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid